Haploidentical peripheral blood stem cell transplantation with posttransplant cyclophosphamide for systemic Epstein-Barr virus-positive T-cell lymphoma of childhood

[1] Henter JI(2007)HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis Pediatr Blood Cancer 48 124-31

[2] Horne A(2018)Hematopoietic stem cell transplantation for the treatment of Epstein-Barr Virus-Associated T- or NK-Cell lymphoproliferative diseases and associated disorders Front Pediatr 6 334-6

[3] Arico M(2015)Successful treatment of immediate allogeneic myeloablative hematopoietic stem cell transplantation from a HLA-mismatched sibling donor for active systemic epstein-barr virus-positive T-cell lymphoproliferative disease of childhood following primary acute epstein-barr virus infection Clin Case Rep 3 231-24

[4] Egeler RM(2016)Modern approaches to HLA-haploidentical blood or marrow transplantation Nat Rev Clin Oncol 13 10-40

[5] Filipovich AH(2015)Haploidentical transplant with posttransplant cyclophosphamide vs matched unrelated donor transplant for acute myeloid leukemia Blood 126 1033-9

[6] Imashuku S(2016)Reduced-intensity transplantation for lymphomas using haploidentical related donors versus HLA-matched sibling donors: a center for international blood and marrow transplant research analysis J Clin Oncol 34 3141-86

[7] Sawada A(2017)Similar outcomes after haploidentical transplantation with post-transplant cyclophosphamide versus HLA-matched transplantation: a meta-analysis of case-control studies Oncotarget 8 63574-8

[8] Inoue M(2011)Alternative donor transplantation after reduced intensity conditioning: results of parallel phase 2 trials using partially HLA-mismatched related bone marrow or unrelated double umbilical cord blood grafts Blood 118 282-30

[9] Kakinoki Y(2019)Haploidentical transplantation with post-transplant cyclophosphamide versus unrelated donor hematopoietic stem cell transplantation: a systematic review and meta-analysis Biol Blood Marrow Transpl 25 2422-31

[10] Matsuoka S(2019)Post transplant cyclophosphamide based haplo-identical transplant versus umbilical cord blood transplant; a meta-analysis Jpn J Clin Oncol 49 924-9

[1] Henter JI(2007)HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis Pediatr Blood Cancer 48 124-31

[2] Horne A(2018)Hematopoietic stem cell transplantation for the treatment of Epstein-Barr Virus-Associated T- or NK-Cell lymphoproliferative diseases and associated disorders Front Pediatr 6 334-6

[3] Arico M(2015)Successful treatment of immediate allogeneic myeloablative hematopoietic stem cell transplantation from a HLA-mismatched sibling donor for active systemic epstein-barr virus-positive T-cell lymphoproliferative disease of childhood following primary acute epstein-barr virus infection Clin Case Rep 3 231-24

[4] Egeler RM(2016)Modern approaches to HLA-haploidentical blood or marrow transplantation Nat Rev Clin Oncol 13 10-40

[5] Filipovich AH(2015)Haploidentical transplant with posttransplant cyclophosphamide vs matched unrelated donor transplant for acute myeloid leukemia Blood 126 1033-9

[6] Imashuku S(2016)Reduced-intensity transplantation for lymphomas using haploidentical related donors versus HLA-matched sibling donors: a center for international blood and marrow transplant research analysis J Clin Oncol 34 3141-86

[7] Sawada A(2017)Similar outcomes after haploidentical transplantation with post-transplant cyclophosphamide versus HLA-matched transplantation: a meta-analysis of case-control studies Oncotarget 8 63574-8

[8] Inoue M(2011)Alternative donor transplantation after reduced intensity conditioning: results of parallel phase 2 trials using partially HLA-mismatched related bone marrow or unrelated double umbilical cord blood grafts Blood 118 282-30

[9] Kakinoki Y(2019)Haploidentical transplantation with post-transplant cyclophosphamide versus unrelated donor hematopoietic stem cell transplantation: a systematic review and meta-analysis Biol Blood Marrow Transpl 25 2422-31

[10] Matsuoka S(2019)Post transplant cyclophosphamide based haplo-identical transplant versus umbilical cord blood transplant; a meta-analysis Jpn J Clin Oncol 49 924-9